In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: An industry survey
- 30 April 2012
- journal article
- research article
- Published by Elsevier BV in Regulatory Toxicology and Pharmacology
- Vol. 62 (3), 449-455
- https://doi.org/10.1016/j.yrtph.2012.01.007
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Comparative Evaluation of in Silico Systems for Ames Test Mutagenicity Prediction: Scope and LimitationsChemical Research in Toxicology, 2011
- The computational prediction of genotoxicityExpert Opinion on Drug Metabolism & Toxicology, 2010
- Benchmark Data Set for in Silico Prediction of Ames MutagenicityJournal of Chemical Information and Modeling, 2009
- Combined Use of MC4PC, MDL-QSAR, BioEpisteme, Leadscope PDM, and Derek for Windows Software to Achieve High-Performance, High-Confidence, Mode of Action–Based Predictions of Chemical Carcinogenesis in RodentsToxicology Mechanisms and Methods, 2008
- The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug developmentRegulatory Toxicology and Pharmacology, 2006
- A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicityRegulatory Toxicology and Pharmacology, 2006
- Computer systems for the prediction of toxicity: an updateAdvanced Drug Delivery Reviews, 2002
- Knowledge-Based Expert Systems for Toxicity and Metabolism Prediction: DEREK, StAR and METEORSAR and QSAR in Environmental Research, 1999
- A New Highly Specific Method for Predicting the Carcinogenic Potential of Pharmaceuticals in Rodents Using EnhancedMCASEQSAR-ES SoftwareRegulatory Toxicology and Pharmacology, 1998
- Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTPMutation Research/Reviews in Genetic Toxicology, 1991